ArticleEClinicalMedicine2025

Safety and efficacy of MCO-010 optogenetic therapy in patients with Stargardt disease in USA (STARLIGHT): an open-label multi-center Ph2 trial.

Byron L Lam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.